UBS sees more downside and than upside in Biogen stock
Go back to UBS sees more downside and than upside in Biogen stock| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 221.50 +8.95 (4.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $212.55 | 52 Week High | $333.65 | |||
| Open | $215.33 | 52 Week Low | $223.02 | |||
| Day High | $221.59 | P/E | 28.36 | |||
| Day Low | $215.08 | EPS | $7.81 | |||
| Volume | 425,100 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1286.37 +60.64 (4.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1225.73 | 52 Week High | $88.16 | |||
| Open | $1245.81 | 52 Week Low | $67.88 | |||
| Day High | $1292.65 | P/E | 297.77 | |||
| Day Low | $1240.54 | EPS | $4.32 | |||
| Volume | 3,320,675 | |||||
